Maturitas

Maturitas is a peer-reviewed medical journal covering research on all aspects of menopause. The journal was established in 1978 and is published by Elsevier. The editor-in-chief is Margaret Rees (University of Oxford). The journal is abstracted and indexed in PubMed/MEDLINE, Scopus, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 3.654.

History[edit | edit source]

Maturitas was established in 1978. It is a peer-reviewed medical journal that focuses on the study of menopause. The journal is published by Elsevier, a renowned publishing company known for its vast collection of scientific, technical, and medical literature.

Scope[edit | edit source]

The scope of Maturitas includes all aspects of menopause. This includes, but is not limited to, clinical and epidemiological research, basic science research, and health and social issues related to menopause.

Editor-in-Chief[edit | edit source]

The current editor-in-chief of Maturitas is Margaret Rees, a professor at the University of Oxford. Rees is known for her extensive research and contributions to the field of menopause.

Abstracting and Indexing[edit | edit source]

Maturitas is abstracted and indexed in several databases. These include PubMed/MEDLINE, Scopus, and the Science Citation Index Expanded. These databases are widely used in the scientific community for research and reference purposes.

Impact Factor[edit | edit source]

According to the Journal Citation Reports, Maturitas has a 2019 impact factor of 3.654. The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal within its field.

Maturitas Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.